Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.22 is in line with its 5-year average of 1.12, near the high end of its 5-year range (0.00–1.38).
As of the fiscal period ended Tuesday, June 30, 2026. 5.46% below its 12-month average of 1.29.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.22.
QUICK RATIO (ACID-TEST)
1.22
QUICK RATIO (ACID-TEST) AVG TTM
1.29
QUICK RATIO (ACID-TEST) AVG 3Y
1.12
QUICK RATIO (ACID-TEST) AVG 5Y
1.12
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-5.46%
CURRENT VS 3Y AVG
+9.13%
CURRENT VS 5Y AVG
+8.77%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.79
median of 396 covered companies
CURRENT VS SECTOR MEDIAN
-56.42%
vs the sector median at left
BrightSpring Health Services, Inc. Common Stock
Market Cap
$12.17B
Quick Ratio (Acid-Test)
1.22
TTM Avg
1.29
3Y Avg
1.12
5Y Avg
1.12
Market Cap
$12.00B
Quick Ratio (Acid-Test)
1.19
TTM Avg
1.06
3Y Avg
1.17
5Y Avg
1.20
Market Cap
$12.52B
Quick Ratio (Acid-Test)
1.32
TTM Avg
1.31
3Y Avg
1.23
5Y Avg
1.40
Market Cap
$12.89B
Quick Ratio (Acid-Test)
0.95
TTM Avg
1.18
3Y Avg
1.19
5Y Avg
1.30
Market Cap
$12.95B
Quick Ratio (Acid-Test)
1.17
TTM Avg
3.59
3Y Avg
3.76
5Y Avg
4.72
Market Cap
$11.36B
Quick Ratio (Acid-Test)
3.35
TTM Avg
2.87
3Y Avg
2.99
5Y Avg
2.87
Market Cap
$13.19B
Quick Ratio (Acid-Test)
2.77
TTM Avg
3.05
3Y Avg
4.30
5Y Avg
5.45
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $12.17B | 1.22 | 1.29 | 1.12 | 1.12 |
| Encompass Health Corporation (EHC)vs › | $12.00B | 1.19 | 1.06 | 1.17 | 1.20 |
| Penumbra, Inc. (PEN)vs › | $12.49B | 3.86 | 3.87 | 3.53 | 3.55 |
| Baxter International Inc. (BAX)vs › | $12.52B | 1.32 | 1.31 | 1.23 | 1.40 |
| DaVita Inc. (DVA)vs › | $11.47B | 1.41 | 1.23 | 1.19 | 1.21 |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 0.95 | 1.18 | 1.19 | 1.30 |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | 1.17 | 3.59 | 3.76 | 4.72 |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 3.35 | 2.87 | 2.99 | 2.87 |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 2.77 | 3.05 | 4.30 | 5.45 |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $11.12B | 1.32 | 3.40 | 2.88 | 2.93 |
Quick Ratio
1.22
Excludes inventory
Current Ratio
1.59
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.22 |
| 2026-03-31 | 1.38 |
| 2025-12-31 | 1.12 |
| 2025-09-30 | 1.38 |
| 2025-06-30 | 1.34 |
| 2025-03-31 | 1.37 |
| 2024-12-31 | 0.88 |
| 2024-09-30 | 0.97 |
| 2024-06-30 | 1.00 |
| 2024-03-31 | 0.96 |
| 2023-12-31 | 0.84 |
| 2023-09-30 | 0.97 |
| 2023-06-30 | 1.07 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 0.98 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
| 2021-12-31 | 0.99 |
| 2021-09-30 | 1.26 |
| 2021-06-30 | 1.30 |
| 2021-03-31 | 1.30 |
| 2020-12-31 | 1.33 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 1.08 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
